Evidence map›Paper›PMID 27199986›Full record

ReviewFrontiers in immunology2016

Post-transcriptional Regulation of Immunological Responses through Riboclustering.

Koelina Ganguly, Jeevan Giddaluru, Avery August, Nooruddin Khan

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Protein Kinase C Theta Modulates PCMT1 through hnRNPL to Regulate FOXP3 Stability in Regulatory T Cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Amino Acid SensingFrontiers in immunology · 2017
    Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Koelina GangulyDepartment of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad , Hyderabad , India.
Jeevan GiddaluruDepartment of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad , Hyderabad , India.
Avery AugustDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University , New York, NY , USA.
Nooruddin KhanDepartment of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad , Hyderabad , India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunological programing of immune cells varies in response to changing environmental signals. This process is facilitated by modifiers that regulate the translational fate of mRNAs encoding various immune mediators, including cytokines and chemokines, which in turn determine the rapid activation, tolerance, and plasticity of the immune system. RNA-binding proteins (RBPs) recruited by the specific sequence elements in mRNA transcripts are one such modifiers. These RBPs form RBP-RNA complexes known as "riboclusters." These riboclusters serve as RNA sorting machinery, where depending upon the composition of the ribocluster, translation, degradation, or storage of mRNA is controlled. Recent findings suggest that this regulation of mRNA homeostasis is critical for controlling the immune response. Here, we present the current knowledge of the ribocluster-mediated post-transcriptional regulation of immune mediators and highlight recent findings regarding their implications for the pathogenesis of acute or chronic inflammatory diseases.

Indexed as

inflammationmRNA stabilitypolysomesstress granulesT cell maturationthymic and peripheral tolerance

Identifiers

PMID27199986
PMCPMC4850162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.